Evidence map›Paper›PMID 38861851›Full record

ReviewCurrent opinion in chemical biology2024

The non-catalytic domains of O-GlcNAc cycling enzymes present new opportunities for function-specific control.

Chia-Wei Hu, Ke Wang, Jiaoyang Jiang

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chia-Wei HuSchool of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave, Madison, WI 53705, USA.
Ke WangSchool of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave, Madison, WI 53705, USA.
Jiaoyang JiangSchool of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave, Madison, WI 53705, USA. Electronic address: jiaoyang.jiang@wisc.edu.

Funding

Chemical Probes to Characterize the Functional States of O-GlcNAc TransferaseR01GM121718 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Jiaoyang Jiang · 2017 to 2026
$3.3M
Structural insights into the functional regulation of O-GlcNAcaseR01GM152998 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Jiaoyang Jiang · 2024 to 2026
$1.1M
NIGMS NIH HHS R01 GM121718NIGMS NIH HHS R01 GM152998
6 · The paper itself

Abstract

O-GlcNAcylation is an essential protein glycosylation governed by two O-GlcNAc cycling enzymes: O-GlcNAc transferase (OGT) installs a single sugar moiety N-acetylglucosamine (GlcNAc) on protein serine and threonine residues, and O-GlcNAcase (OGA) removes them. Aberrant O-GlcNAcylation has been implicated in various diseases. However, the large repertoire of more than 1000 O-GlcNAcylated proteins and the elusive mechanisms of OGT/OGA in substrate recognition present significant challenges in targeting the dysregulated O-GlcNAcylation for therapeutic development. Recently, emerging evidence suggested that the non-catalytic domains play critical roles in regulating the functional specificity of OGT/OGA via modulating their protein interactions and substrate recognition. Here, we discuss recent studies on the structures, mechanisms, and related tools of the OGT/OGA non-catalytic domains, highlighting new opportunities for function-specific control.

Indexed as

Acetylglucosaminebeta-N-AcetylhexosaminidasesN-AcetylglucosaminyltransferasesAnimalsGlycosylationHumansProtein DomainsSubstrate SpecificityAcetylglucosaminebeta-N-Acetylhexosaminidaseshexosaminidase CN-AcetylglucosaminyltransferasesO-GlcNAc transferaseFunction-specific modulatorNon-catalytic domainO-GlcNAcase (OGA)O-GlcNAc transferase (OGT)

Identifiers

PMID38861851
PMCPMC11323188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.